Journal of addiction medicine · 2026
Visiting Nurse Services-facilitated Outpatient Low-dose Buprenorphine Initiation and Engagement in Severe Mental Illness and Ongoing Fentanyl Use: A Case Report.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Arbelo Cruz Fabiola, Castillo Jean C, Pérez Palmer Nicolas
Аннотация
BACKGROUND AND OBJECTIVES: Outpatient low-dose buprenorphine initiation (LDBI) is challenging for individuals with severe mental illness and poor treatment adherence. Visiting nurse services (VNS) may support LDBI in these complex patients.
METHODS: We present a 64-year-old male with opioid use disorder, schizoaffective disorder, and post-traumatic stress disorder who underwent outpatient LDBI supported by VNS.
RESULTS: VNS managed medication administration and adherence monitoring, facilitating successful LDBI and sustained engagement.
DISCUSSION AND CONCLUSIONS: VNS facilitated outpatient LDBI and buprenorphine treatment engagement in a patient with fluctuating psychiatric illness and ongoing fentanyl use.
SCIENTIFIC SIGNIFICANCE: This case suggests that VNS may facilitate outpatient LDBI and engagement among clinically complex patients in the fentanyl era.
METHODS: We present a 64-year-old male with opioid use disorder, schizoaffective disorder, and post-traumatic stress disorder who underwent outpatient LDBI supported by VNS.
RESULTS: VNS managed medication administration and adherence monitoring, facilitating successful LDBI and sustained engagement.
DISCUSSION AND CONCLUSIONS: VNS facilitated outpatient LDBI and buprenorphine treatment engagement in a patient with fluctuating psychiatric illness and ongoing fentanyl use.
SCIENTIFIC SIGNIFICANCE: This case suggests that VNS may facilitate outpatient LDBI and engagement among clinically complex patients in the fentanyl era.